Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis

被引:35
作者
Sakamoto, Noriho [1 ]
Ishimoto, Hiroshi [1 ]
Nakashima, Shota [1 ]
Yura, Hirokazu [1 ]
Miyamura, Takuto [1 ]
Okuno, Daisuke [1 ]
Hara, Atsuko [1 ]
Kitazaki, Takeshi [2 ]
Kakugawa, Tomoyuki [1 ]
Ishimatsu, Yuji [3 ]
Satoh, Minoru [4 ]
Mukae, Hiroshi [1 ]
机构
[1] Nagasaki Univ, Dept Resp Med, Sch Biomed Sci, Nagasaki, Japan
[2] Japanese Red Cross Nagasaki Genbaku Hosp, Dept Resp Med, Nagasaki, Japan
[3] Nagasaki Univ, Grad Sch Biomed Sci, Unit Rehabil Sci, Dept Cardiopulm Rehabil Sci, Nagasaki, Japan
[4] Univ Occupat & Environm Hlth, Sch Hlth Sci, Dept Clin Nursing, Kitakyushu, Fukuoka, Japan
关键词
acute interstitial pneumonia; anti-melanoma differentiation-associated gene 5; clinically amyopathic dermatomyositis; AMYOPATHIC DERMATOMYOSITIS; JAPANESE PATIENTS; AUTOANTIBODIES;
D O I
10.2169/internalmedicine.1516-18
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody is associated with rapidly progressive interstitial lung disease (RP-ILD) in patients with clinically amyopathic dermatomyositis (CADM) or dermatomyositis (DM). We herein report three Japanese cases of anti-MDA5 antibody-positive RP-ILD without signs of CADM or DM. High-resolution computed tomography revealed patchy or subpleural distribution of consolidations and/or ground-glass opacities accompanied by traction bronchiectasis. All patients succumbed to respiratory failure within two months. Anti-MDA5 antibody-positive RP-ILD without signs of CADM or DM should be included in the differential diagnosis of acute/subacute ILD. Measurement of anti-MDA5 antibody and an intensive immunosuppressive regimen might rescue these patients from RP-ILD.
引用
收藏
页码:837 / 841
页数:5
相关论文
共 19 条
[1]   Radiological and Pathological Correlation in Anti-MDA5 Antibody-positive Interstitial Lung Disease: Rapidly Progressive Perilobular Opacities and Diffuse Alveolar Damage [J].
Chino, Haruka ;
Sekine, Akimasa ;
Baba, Tomohisa ;
Iwasawa, Tae ;
Okudela, Koji ;
Takemura, Tamiko ;
Itoh, Harumi ;
Sato, Shinji ;
Suzuki, Yasuo ;
Ogura, Takashi .
INTERNAL MEDICINE, 2016, 55 (16) :2241-2246
[2]   Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis [J].
Gono, Takahisa ;
Sato, Shinji ;
Kawaguchi, Yasushi ;
Kuwana, Masataka ;
Hanaoka, Masanori ;
Katsumata, Yasuhiro ;
Takagi, Kae ;
Baba, Sayumi ;
Okamoto, Yuko ;
Ota, Yuko ;
Yamanaka, Hisashi .
RHEUMATOLOGY, 2012, 51 (09) :1563-1570
[3]   Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review [J].
Gonzalez-Moreno, Juan ;
Raya-Cruz, Manuel ;
Losada-Lopez, Ines ;
Paula Cacheda, Ana ;
Oliver, Cristina ;
Colom, Bartomeu .
RHEUMATOLOGY INTERNATIONAL, 2018, 38 (07) :1293-1296
[4]   Clinical Correlations With Dermatomyositis-Specific Autoantibodies in Adult Japanese Patients With Dermatomyositis A Multicenter Cross-sectional Study [J].
Hamaguchi, Yasuhito ;
Kuwana, Masataka ;
Hoshino, Kana ;
Hasegawa, Minoru ;
Kaji, Kenzo ;
Matsushita, Takashi ;
Komura, Kazuhiro ;
Nakamura, Motonobu ;
Kodera, Masanari ;
Suga, Norihiro ;
Higashi, Akira ;
Ogusu, Koji ;
Tsutsui, Kiyohiro ;
Furusaki, Akira ;
Tanabe, Hiroshi ;
Sasaoka, Shunsuke ;
Muro, Yoshinao ;
Yoshikawa, Mika ;
Ishiguro, Naoko ;
Ayano, Masahiro ;
Muroi, Eiji ;
Fujikawa, Keita ;
Umeda, Yukihiro ;
Kawase, Masaaki ;
Mabuchi, Eriko ;
Asano, Yoshihide ;
Sodemoto, Kinuyo ;
Seishima, Mariko ;
Yamada, Hidehiro ;
Sato, Shinichi ;
Takehara, Kazuhiko ;
Fujimoto, Manabu .
ARCHIVES OF DERMATOLOGY, 2011, 147 (04) :391-398
[5]   Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split? [J].
Ikeda, Satoshi ;
Arita, Machiko ;
Morita, Mitsunori ;
Ikeo, Satoshi ;
Ito, Akihiro ;
Tokioka, Fumiaki ;
Noyama, Maki ;
Misaki, Kenta ;
Notohara, Kenji ;
Ishida, Tadashi .
BMC PULMONARY MEDICINE, 2015, 15
[6]   The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM [J].
Koga, Tomohiro ;
Fujikawa, Keita ;
Horai, Yoshiro ;
Okada, Akitomo ;
Kawashiri, Shin-ya ;
Iwamoto, Naoki ;
Suzuki, Takahisa ;
Nakashima, Yoshikazu ;
Tamai, Mami ;
Arima, Kazuhiko ;
Yamasaki, Satoshi ;
Nakamura, Hideki ;
Origuchi, Tomoki ;
Hamaguchi, Yasuhito ;
Fujimoto, Manabu ;
Ishimatsu, Yuji ;
Mukae, Hiroshi ;
Kuwana, Masataka ;
Kohno, Shigeru ;
Eguchi, Katsumi ;
Aoyagi, Kiyoshi ;
Kawakami, Atsushi .
RHEUMATOLOGY, 2012, 51 (07) :1278-1284
[7]  
Kurasawa K, 2018, RHEUMATOLOGY
[8]   Clinical and serological features of patients with dermatomyositis complicated by spontaneous pneumomediastinum [J].
Ma, Xiaolei ;
Chen, Zhiyong ;
Hu, Wei ;
Guo, Ziwei ;
Wang, Yan ;
Kuwana, Masataka ;
Sun, Lingyun .
CLINICAL RHEUMATOLOGY, 2016, 35 (02) :489-493
[9]   Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis [J].
Matsushita, T. ;
Mizumaki, K. ;
Kano, M. ;
Yagi, N. ;
Tennichi, M. ;
Takeuchi, A. ;
Okamoto, Y. ;
Hamaguchi, Y. ;
Murakami, A. ;
Hasegawa, M. ;
Kuwana, M. ;
Fujimoto, M. ;
Takehara, K. .
BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (02) :395-402
[10]   Clinical Differences Between Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis and Classic Dermatomyositis [J].
Mukae, Hiroshi ;
Ishimoto, Hiroshi ;
Sakamoto, Noriho ;
Hara, Shintaro ;
Kakugawa, Tomoyuki ;
Nakayama, Seiko ;
Ishimatsu, Yuji ;
Kawakami, Atsushi ;
Eguchi, Katsumi ;
Kohno, Shigeru .
CHEST, 2009, 136 (05) :1341-1347